Baseline <sup>18</sup>F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study.

Hemasphere · 2023 · PMC9875954 · PMID 36713354

Europe PMC DOI

hedged sentence

0.0090

closest p · 0.2× alpha

0.0090

boldest claim

The sentences

highly significantP = 0.009actually significant

TMTV ≥ 135 cm 3 was highly significant at univariate analysis ( P = 0.009).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.